Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later19. April 2026
News Foundation models are medtech’s newest trend. But what are they?Healthradar15. September 2025 Editor’s note: This is the first story in a two-part series on the use of foundation models in the medtech…
News Heart devices pace medtech’s summer funding flowsHealthradar18. August 2025 Venture capital investment in medtech surged at the start of 2025, prompting PitchBook to forecast a strong year ahead for…
